Patents by Inventor Margot Paulick

Margot Paulick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12234225
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: February 25, 2025
    Assignee: DICE ALPHA, INC.
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter Van Der Linden, Timothy J. Church, Claudio Aquino, Margot Paulick
  • Publication number: 20240400555
    Abstract: A method of modulating c-MYC activity is disclosed.
    Type: Application
    Filed: April 26, 2024
    Publication date: December 5, 2024
    Applicant: Initial Therapeutics, Inc.
    Inventors: Phillip A. Patten, Jim Li, Brooke Olson Blair, Pingyu Ding, Yi Chiao Fan, Margot Paulick, Martin Linsell
  • Publication number: 20230053746
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Application
    Filed: July 15, 2022
    Publication date: February 23, 2023
    Inventors: Paul R. FATHEREE, Martin S. LINSELL, John R. JACOBSEN, Wouter VAN DER LINDEN, Timothy J. CHURCH, Claudio AQUINO, Margot PAULICK
  • Patent number: 11447468
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: September 20, 2022
    Assignee: DICE ALPHA, INC.
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter Van der Linden, Timothy J. Church, Claudio Aquino, Margot Paulick
  • Publication number: 20200247785
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Application
    Filed: February 6, 2020
    Publication date: August 6, 2020
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter Van der Linden, Timothy J. Church, Claudio Aquino, Margot Paulick